Quantitative Sentinel System
by Quantitative Medicine, Inc. 2 variants
510(k) K960109
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK960109 | Date1 Aug 1996 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- HGM
- Device Class
- Class II
- Regulation
- 21 CFR Part 884.2740
- Advisory Committee
- Obstetrics/Gynecology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 25 Sep 2026
The Quantitative Sentinel System is a System, Monitoring, Perinatal device intended for use as a clinical data management system. It is classified under product code HGM and regulation number 884.2740, with a device class of II and specialty in Obstetrics/Gynecology.
The device received FDA 510(k) clearance under K960109 on August 1, 1996, following a traditional review process. It was submitted by Quantitative Medicine, Inc. and is classified as substantially equivalent to a predicate device. The system is supplied as a non-sterile, reusable software-based system for use in clinical perinatal monitoring settings.
Other devices from Quantitative Medicine, Inc.
Questions
AI-generated answers, 25 Sep 2026
What is the Quantitative Sentinel System used for?
The Quantitative Sentinel System is intended for use as a clinical data management system in perinatal monitoring settings, supporting the collection, organization, and analysis of obstetric and gynecologic patient data to assist clinicians in monitoring maternal and fetal status during pregnancy and labor.
Is the Quantitative Sentinel System sterile or non-sterile, and is it reusable or single-use?
The system is supplied as a non-sterile, reusable software-based system, meaning it does not require sterilization before use and is designed for multiple uses in clinical environments after appropriate software and hardware maintenance, as it contains no disposable components that contact the patient directly.
How was the Quantitative Sentinel System cleared for market release?
The device received FDA 510(k) clearance under submission K960109 on August 1, 1996, following a traditional review process, and was determined to be substantially equivalent to a legally marketed predicate device, which allowed it to be marketed for its intended use in perinatal clinical data management.